Newsroom | 2111 results

MCLEAN, Va.--(BUSINESS WIRE)--BigBear.ai Holdings, Inc. (NYSE: BBAI) (“BigBear.ai” or the “Company”), a leader in AI-powered decision intelligence solutions, today announced financial results for the third quarter of 2025 and issued an investor presentation that has been posted to the Investor Relations section of the Company’s website. “Today, I’m thrilled to announce that BigBear.ai has signed a definitive agreement to acquire Ask Sage, a cutting-edge and fast-growing Generative AI platform f...

MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the University of Idaho College of Business and Economics, beginning in the Spring 2026 semester. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds’ commitment to fostering innovation, leadership, and discovery across the he...

WASHINGTON--(BUSINESS WIRE)--OpenAge, an initiative led by k-ID, debuted today at the Family Online Safety Institute (FOSI) Annual Conference. OpenAge brings together global policy & safety experts, leading platforms and providers of trusted age signals, to establish a user-centric, privacy-first framework for age assurance globally. The OpenAge Initiative is solving what has long been viewed as the internet’s insurmountable challenge: how to at the scale of the internet and in a privacy pr...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting on November 7-10, 2025 in National Harbor, Maryland. The company will showcase how researchers can generate a combination of high-quality RNA and protein data via Vizgen’s bioinformatics technology. Vizgen combined results...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--GXP-Storage’s ISO 20387:2018 and 9001:2015 certifications creates a comprehensive dual ISO quality framework for regulated material management....

DOVER, Del.--(BUSINESS WIRE)--Identy.io announced it achieved NIST ISO 30107-3 Level 2 PAD Certification with a perfect score for its Face SDK v6.3.0 application....

INGELHEIM, Germany and ZURICH, Switzerland--(BUSINESS WIRE)--Boehringer Ingelheim and CDR-Life, Inc. today announced a new global licensing agreement to develop CDR-Life’s unique antibody-based molecule CDR111 for autoimmune diseases. CDR111 is a trispecific M-gager®, an antibody-based T-cell engager designed to selectively target and deplete B cells, with the goal of achieving immune system reset. Dysregulated B cells play a central role in driving many autoimmune and inflammatory conditions s...

BARCELONA, Spain--(BUSINESS WIRE)--REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company seeking to revolutionize precision oncology through biomarker innovation, today announced the publication of the study “HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy” in Nature Communications. This landmark study evaluated the HER2DX genomic assay in 154 individuals aged 70–80 years enrolled in the RESPECT tr...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for the third quarter ended September 30, 2025, compared to $709 million for the same period of 2024. “Exact Sciences continues to advance our mission to prevent cancer and detect it earlier through a relentless focus on patients,” said Kevin Conroy, chairman and CEO. “Our third quarter results reflec...

LONDON--(BUSINESS WIRE)--iProov, the world's leading provider of science-based biometric identity verification solutions, today announced that it is the first and only vendor to meet the biometric verification requirements included in the new NIST Special Publication 800-63-4 Digital Identity Guidelines. This achievement is independently established by the combination of recent testing of iProov Dynamic Liveness by an ISO-accredited lab to the new CEN18099 injection attack standard, together wi...